This is consistent with in vitro studies in which the autocrine production of IL-6 in breast cancer cells was demonstrated to increase MDR expression within the tumor cells themselves (Borsellino et al, 1995; Conze et al, 2001). This evidence concerns the gene IL6 and breast carcinoma.